On-demand education

Prostate Cancer
Type

Robotic radical prostatectomy

Duration: Approx. 60 minutes

Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice

Duration: 60

Prof. Mottet and Prof. Cornford discuss active surveillance for prostate cancer

Duration: Approx. 35 minutes

Dr. Constance Thibault talks about triplet therapy in mHSPC

Duration: 6 minutes

PARP Inhibitor in Prostate Cancer. Part III

Duration: 60

WHO 2022 Classification of Male Genitourinary Tract tumor: What is relevant? Novelties for the practicing urologist?

Duration: Approx. 60 minutes

Prof. Nicolas Mottet about the changes in the 2022 guidelines for prostate cancer - Part 2

Duration: 21 minutes

Prof. Nicolas Mottet about the changes in the 2022 guidelines for prostate cancer - Part 1

Duration: 15 minutes

Advanced Prostate Cancer – Non-Metastatic Hormone-Sensitive Prostate Cancer (nmHSPC)

Duration: Approx. 120 minutes

PARP inhibitors in prostate cancer. Part 2

Duration: 70

Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments

Duration: Approx 60 minutes

Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice

Duration: Approx. 50 minutes

Artificial intelligence: The role for research and patient treatment

Duration: Approx. 70 minutes

UROwebinar: PARP inhibitors in prostate cancer. Part 1

Duration: Approx. 60 minutes

Identification and management of patients with nmCRPC

Duration: Approx. 60 – 90 minutes

Future directions in PCa management

Duration: Approx. 60 – 90 minutes